Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias K Freynhofer

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Wiener Medizinische Wochenschrift (1946)|November 13, 2012
Biomarkers in acute coronary artery diseaseMatthias K Freynhofer, Miloš Tajsić, Johann Wojta, et al.
Current Pharmaceutical Design|June 26, 2012
The role of platelets in athero-thrombotic eventsMatthias K Freynhofer, Veronika Bruno, Johann Wojta, et al.
Thrombosis and Haemostasis|April 12, 2011
Genetic variability in response to clopidogrel therapy and its clinical implicationsLiana Yukhanyan, Matthias K Freynhofer, Jolanta Siller-Matula, et al.
Thrombosis and Haemostasis|January 26, 2012
Vasodilator-stimulated phosphoprotein-phosphorylation assay in patients on clopidogrel: does standardisation matter?Matthias K Freynhofer, Veronika Bruno, Martin Willheim, et al.
European Heart Journal. Case Reports|January 14, 2022
Multisystem inflammatory syndrome in adults in a young male following severe acute respiratory syndrome coronavirus-2 infection: a case reportChristoph C Kaufmann, Alexander Simon, David Reinhart-Mikocki, et al.
European Heart Journal. Acute Cardiovascular Care|December 17, 2013
Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary interventionMiklos Rohla, Matthias K Freynhofer, Ioannis Tentzeris, et al.
Thrombosis and Haemostasis|August 15, 2015
Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testingMatthias K Freynhofer, Susanne C Gruber, Erik L Grove, et al.
European Heart Journal. Acute Cardiovascular Care|November 20, 2016
Epicardial adipose tissue and cardiovascular outcome in patients with acute coronary syndrome undergoing percutaneous coronary interventionMaximilian Tscharre, Christina Hauser, Miklos Rohla, et al.
International Journal of Cardiology|October 9, 2012
Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillationMatthias K Freynhofer, Susanne C Gruber, Veronika Bruno, et al.
Open Heart|October 15, 2016
Systematic screening for cardiovascular risk at pharmaciesMiklos Rohla, Heinz Haberfeld, Helmut Sinzinger, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Wiener Medizinische Wochenschrift (1946)|November 13, 2012
Biomarkers in acute coronary artery diseaseMatthias K Freynhofer, Miloš Tajsić, Johann Wojta, et al.
Current Pharmaceutical Design|June 26, 2012
The role of platelets in athero-thrombotic eventsMatthias K Freynhofer, Veronika Bruno, Johann Wojta, et al.
Thrombosis and Haemostasis|April 12, 2011
Genetic variability in response to clopidogrel therapy and its clinical implicationsLiana Yukhanyan, Matthias K Freynhofer, Jolanta Siller-Matula, et al.
Thrombosis and Haemostasis|January 26, 2012
Vasodilator-stimulated phosphoprotein-phosphorylation assay in patients on clopidogrel: does standardisation matter?Matthias K Freynhofer, Veronika Bruno, Martin Willheim, et al.
European Heart Journal. Case Reports|January 14, 2022
Multisystem inflammatory syndrome in adults in a young male following severe acute respiratory syndrome coronavirus-2 infection: a case reportChristoph C Kaufmann, Alexander Simon, David Reinhart-Mikocki, et al.
European Heart Journal. Acute Cardiovascular Care|December 17, 2013
Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary interventionMiklos Rohla, Matthias K Freynhofer, Ioannis Tentzeris, et al.
Thrombosis and Haemostasis|August 15, 2015
Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testingMatthias K Freynhofer, Susanne C Gruber, Erik L Grove, et al.
European Heart Journal. Acute Cardiovascular Care|November 20, 2016
Epicardial adipose tissue and cardiovascular outcome in patients with acute coronary syndrome undergoing percutaneous coronary interventionMaximilian Tscharre, Christina Hauser, Miklos Rohla, et al.
International Journal of Cardiology|October 9, 2012
Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillationMatthias K Freynhofer, Susanne C Gruber, Veronika Bruno, et al.
Open Heart|October 15, 2016
Systematic screening for cardiovascular risk at pharmaciesMiklos Rohla, Heinz Haberfeld, Helmut Sinzinger, et al.
Pageof 4